APA Alıntı

Caballero-Velázquez, T., Sánchez-Abarca, L. I., Gutierrez-Cosio, S., Blanco, B., Calderon, C., Herrero, C., . . . Pérez-Simón, J. A. (2012). The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation. Ferrata Storti Foundation.

Chicago Stili Alıntı

Caballero-Velázquez, Teresa, et al. The Novel Combination of Sirolimus and Bortezomib Prevents Graft-versus-host Disease but Maintains the Graft-versus-leukemia Effect After Allogeneic Transplantation. Ferrata Storti Foundation, 2012.

MLA Alıntı

Caballero-Velázquez, Teresa, et al. The Novel Combination of Sirolimus and Bortezomib Prevents Graft-versus-host Disease but Maintains the Graft-versus-leukemia Effect After Allogeneic Transplantation. Ferrata Storti Foundation, 2012.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..